The results of the present study revealed a significant increase in the gene expression levels of NLRP3, ASC, and caspase-1 along with elevated serum levels of IL-1β in RRMS patients compared to healthy controls. Here, CASP1 is linked to relapsing-remitting multiple sclerosis.